Search: Web pages   News  

Mesothelioma Prognosis - search results

Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American ... (PR Newswire via Yahoo! Finance)
dexamethasone) in multiple myeloma patients relapsed from or refractory to bortezomib
us.rd.yahoo.com